Edition:
India

Aethlon Medical Inc (AEMD.OQ)

AEMD.OQ on NASDAQ Stock Exchange Capital Market

1.27USD
15 Dec 2017
Change (% chg)

-- (--)
Prev Close
$1.27
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
101,534
52-wk High
$5.17
52-wk Low
$0.80

Latest Key Developments (Source: Significant Developments)

Aethlon Medical announces second quarter results
Friday, 3 Nov 2017 

Nov 2 (Reuters) - Aethlon Medical Inc :Aethlon Medical announces fiscal 2018 second quarter results.Q2 loss per share $0.14.  Full Article

AETHLON MEDICAL ANNOUNCES PRODUCTION COLLABORATION WITH IBIO INC
Monday, 16 Oct 2017 

Oct 16 (Reuters) - Aethlon Medical Inc ::AETHLON MEDICAL ANNOUNCES LARGE-SCALE PRODUCTION COLLABORATION.AETHLON MEDICAL INC - HAS ESTABLISHED A COLLABORATION WITH IBIO INC. TO SUPPORT POTENTIAL LARGE-SCALE PRODUCTION OF AETHLON HEMOPURIFIER​.  Full Article

IBIO ANNOUNCES MANUFACTURING COLLABORATION WITH AETHLON MEDICAL
Monday, 16 Oct 2017 

Oct 16 (Reuters) - iBio Inc ::IBIO ANNOUNCES MANUFACTURING COLLABORATION WITH AETHLON MEDICAL.IBIO INC - ‍AGREEMENT WITH AETHLON MEDICAL INC TO SUPPORT POTENTIAL LARGE-SCALE PRODUCTION OF AETHLON HEMOPURIFIER BLOOD PURIFICATION DEVICE​.  Full Article

Intracoastal Capital reports 5.7 pct passive stake in Aethlon Medical
Thursday, 12 Oct 2017 

Oct 11 (Reuters) - Aethlon Medical Inc :Intracoastal Capital LLC reports 5.7 percent passive stake in Aethlon Medical Inc as of Oct 2 - SEC filing‍​.  Full Article

Aethlon Medical reports Q1 loss per share $0.28
Friday, 12 Aug 2016 

Aethlon Medical Inc : Aethlon medical announces fiscal 2017 first quarter results . Q1 loss per share $0.28 .Qtrly government contract revenue $4,635 versus $192,508 a year ago.  Full Article

Aethlon Medical announces Zika virus data
Thursday, 11 Aug 2016 

Aethlon Medical Inc: Agreement with defense advanced research projects agency to validate in vitro capture of middle east respiratory syndrome coronavirus . Its researchers have completed in vitro studies that demonstrate "rapid capture" of zika virus by Aethlon hemopurifier . The zika studies demonstrated a 95% clearance of zika virus from cell culture fluid in 5.5 hours .Zika studies demonstrated an approximate 50% clearance of zika from human blood serum in 5 hours.  Full Article

BRIEF-Aethlon Medical Names Dr. Charles J. Fisher Chairman Of The Board

* AETHLON MEDICAL NAMES DR. CHARLES J. FISHER CHAIRMAN OF THE BOARD Source text for Eikon: Further company coverage: